REDWOOD CITY, Calif., Aug. 8, 2014 /PRNewswire/ -- Guardant Health, a life sciences company focused on the development and commercialization of oncology diagnostic products, announced today that AmirAli Talasaz, Ph.D., President and Chief Technology Officer will present at the WedBush Life Sciences Management Access Conference. The presentation will take place at the Le Parker Meridien in New York, NY on August 12, 2014 at 9:45 am ET.
Dr. Talasaz will provide an overview of the company and Guardant360(®), a breakthrough blood test that enables real-time tracking of a patient's cancer genomics and associated treatment options.
About Guardant Health?
Guardant Health is focused on developing breakthrough diagnostic technologies that possess the ability to transform cancer from a terminal illness to a manageable disease. Guardant was founded in 2012 by a team of entrepreneurs with high-ranking expertise in next-generation sequencing, single-cell genomics and cancer diagnostics. Guardant Health is committed to contributing a positive significant impact on patient health through cutting-edge technology that addresses long-standing unmet needs in oncology. https://www.guardanthealth.com
SOURCE Guardant Health